학술논문

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer
Document Type
Article
Source
In: International Journal of Clinical Oncology. (International Journal of Clinical Oncology, May 2022, 27(5):850-862)
Subject
Language
English
ISSN
14377772
13419625